Cargando…
USP22 Promotes NSCLC Tumorigenesis via MDMX Up-Regulation and Subsequent p53 Inhibition
Increasing evidence suggests that ubiquitin-specific protease 22 (USP22) has great clinicopathologic significance in oncology. In this study, we investigated the role of USP22 in human NSCLC tumorigenesis along with the underlying mechanisms of action. First, we determined the expression of USP22 in...
Autores principales: | Ding, Fangbao, Bao, Chunrong, Tian, Yue, Xiao, Haibo, Wang, Mingsong, Xie, Xiao, Hu, Fengqing, Mei, Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307248/ https://www.ncbi.nlm.nih.gov/pubmed/25547493 http://dx.doi.org/10.3390/ijms16010307 |
Ejemplares similares
-
Rho GTPase Activating Protein 24 (ARHGAP24) Silencing Promotes Lung Cancer Cell Migration and Invasion by Activating β-Catenin Signaling
por: Wang, Lei, et al.
Publicado: (2019) -
Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression
por: Xu, Pei, et al.
Publicado: (2020) -
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
por: Qi, Si-Min, et al.
Publicado: (2020) -
Functions of MDMX in the Modulation of the p53-Response
por: Lenos, Kristiaan, et al.
Publicado: (2011) -
Down Regulation of SIRT2 Reduced ASS Induced NSCLC Apoptosis Through the Release of Autophagy Components via Exosomes
por: Wang, Lei, et al.
Publicado: (2020)